Metropolis Healthcare Limited, one of India’s prominent diagnostic chains, has reported a significant year-on-year profit growth of 31.0% in Q2 FY2024-25. This sharp increase is attributed to rising patient volumes, boosted revenue per patient, and robust operational performance. The financial highlights reveal that the company’s revenue from operations reached INR 350 crores, marking a 13.4% […]
Metropolis Healthcare Limited (NSE: METROPOLIS | BSE: 542650), a leading diagnostic chain in India, has announced a significant financial milestone with a 13.1% year-on-year increase in revenue for the first quarter of the fiscal year 2025. The company achieved a revenue of INR 313.4 crores, surpassing the industry average growth rate. Strong Financial Performance For […]
Metropolis Healthcare, an Indian diagnostic service provider, has wrapped up the previously announced INR 636 crores acquisition of Dr. Ganesan’s Hitech Diagnostic Centre along with its subsidiary Centralab Healthcare Services. The acquisition was funded by Metropolis Healthcare via internal accruals and debt of INR 300 crores. Dr. SP Ganesan, who is the promoter and founder […]
Metropolis Healthcare indicated that its previously announced acquisition of Dr. Ganesan’s Hitech Diagnostic Centre and its subsidiary Centralab Healthcare Services is likely to be terminated. The Indian chain of pathology labs and diagnostic centers said that the closing of the cash and stock deal has been delayed by the sellers in fulfilling their obligations under […]